BRIDGEWATER, N.J., May 22, 2024--Amneal to Participate at Upcoming Investor Conference
BRIDGEWATER, N.J., May 22, 2024--Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a sale of 38,000 shares of the company.